Recurrent infection and deterioration of lung function are the major causes of morbidity and mortality in cystic fibrosis (CF). Although various mechanisms relating defective CFTR function to CF lung disease have been proposed, the two principal hypotheses that have emerged are: Na+ hyperabsorption/airway surface liquid (ASL) dehydration and defective airway submucosal gland function. We will use novel measurement methods and model systems to define the role of submucosal glands and airway surface epithelium in CF lung disease, and their correction by small-molecule activators of AF508-CFTR.
In Aim 1, the mechanisms of defective airway submucosal gland function in CF lung disease will be defined. We propose that impaired submucosal gland fluid and HCO3- secretion in CF airways results in a hyperviscous and acidic ASL, which promotes bacterial colonization and CF lung disease. Ion (Na+, CI-, HCO3-) and water transport will be measured in glands in intact, non-CF and CF human airways, partially microdissected/exposed glands, and primary cultures of gland serous and mucous cells. The second part of Aim 1 will link defective gland function to CF lung disease, using collected non-CF vs. CF gland fluid.
In Aim 2, we will determine the contributions of defective gland vs. airway surface function to ASL abnormalities in CF. We will critically examine the 'ASL dehydration'hypothesis using human airways, testing whether ASL volume is reduced in CF, how ASL volume is regulated in intact airways, and the role of submucosal glands vs. surface epithelium in regulating ASL volume.
In Aim 3, small-molecule correctors of AF508-CFTR will be used to test whether restoration of CI- transport in CF epithelia corrects gland/ASL defects in CF. It has been assumed that replacing (by gene therapy) or restoring (by small-molecules) CFTR CI- transport in CF will be beneficial in preventing lung disease.
This aim follows from our discovery of small-molecule correctors of defective gating and cellular processing of AF508-CFTR. Novel, fluorescence-based assays in airway spheroids and primary cell cultures will be used to evaluate small-molecule efficacy in restoring epithelial cell CI- conductance. Gland function and ASL properties will be measured in small-molecule-treated cell cultures and ex vivo tissues. The data will provide a rigorous scientific rationale for use of small-molecules in CF therapy, and establish widely useful assays to prioritize small molecules for clinical development.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL073856-07
Application #
7644977
Study Section
Lung Cellular, Molecular, and Immunobiology Study Section (LCMI)
Program Officer
Banks-Schlegel, Susan P
Project Start
2003-09-01
Project End
2011-08-31
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
7
Fiscal Year
2009
Total Cost
$386,250
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Owens, Gregory P; Ritchie, Alanna; Rossi, Andrea et al. (2015) Mutagenesis of the aquaporin 4 extracellular domains defines restricted binding patterns of pathogenic neuromyelitis optica IgG. J Biol Chem 290:12123-34
Asavapanumas, Nithi; Ratelade, Julien; Verkman, A S (2014) Unique neuromyelitis optica pathology produced in naïve rats by intracerebral administration of NMO-IgG. Acta Neuropathol 127:539-51
Ye, Long; Hu, Bao; El-Badri, Faris et al. (2014) ?F508-CFTR correctors: synthesis and evaluation of thiazole-tethered imidazolones, oxazoles, oxadiazoles, and thiadiazoles. Bioorg Med Chem Lett 24:5840-5844
Asavapanumas, Nithi; Ratelade, Julien; Papadopoulos, Marios C et al. (2014) Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G. J Neuroinflammation 11:16
Verkman, A S; Phuan, Puay-Wah; Asavapanumas, Nithi et al. (2013) Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO. Brain Pathol 23:684-95
Zhang, Hua; Verkman, A S (2013) Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica. J Clin Invest 123:2306-16
Levin, Marc H; Bennett, Jeffrey L; Verkman, A S (2013) Optic neuritis in neuromyelitis optica. Prog Retin Eye Res 36:159-71
Phuan, Puay-Wah; Zhang, Hua; Asavapanumas, Nithi et al. (2013) C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Acta Neuropathol 125:829-40
Ratelade, Julien; Asavapanumas, Nithi; Ritchie, Alanna M et al. (2013) Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica. Acta Neuropathol 126:699-709
Jin, Byung-Ju; Ko, Eun-A; Namkung, Wan et al. (2013) Microfluidics platform for single-shot dose-response analysis of chloride channel-modulating compounds. Lab Chip 13:3862-7

Showing the most recent 10 out of 160 publications